Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 2, 2000, Pages 183-189

  Babini, Gioia S ^a   Livermore, David M ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFEPIME; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; CLOXACILLIN; ENZYME INHIBITOR; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RO 48 1256; TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG HYDROLYSIS; ENZYME SYNTHESIS; FOLLOW UP; GRAM NEGATIVE INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SOUTHERN EUROPE; WESTERN EUROPE;

EID: 0033961902     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.2.183     Document Type: Article

References (14)

1. Podschun, R. & Ullmann, U. (1998). Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clinical Microbiology Reviews 11, 589-603.
2. Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39, 1211-33.
3. Fournier, B., Arlet, G., Lagrange, P. H. & Philippon, A. (1994). Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded β-lactamase. FEMS Microbiology Letters 116, 31-6.
4. Livermore, D. M. & Yuan, M. (1996). Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. Journal of Antimicrobial Chemotherapy 38, 409-24.
5. Heinze-Krauss, I., Angehrn, P., Charnas, R. L., Gubernator, K., Gutknecht, E. M., Hubschwerlen, C. et al. (1998). Structure-based design of β-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams. Journal of Medicinal Chemistry 41, 3961 -71.
6. Livermore, D. M. & Williams, J. D. (1996). β-Lactams: mode of action and mechanisms of antibacterial resistance. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 502-77. Williams & Wilkins, Baltimore, MD.
7. Swinscow, T. D. (1976). Statistics at square one. XV - The chisquared tests (continued). British Medical Journal 2, 513-4.
8. Livermore, D. M. (1993). Determinants of the activity of β-lactamase inhibitor combinations. Journal of Antimicrobial Chemotherapy 31, Suppl. A, 9-21.
9. Gheorghiu, R., Yuan, M., Hall, L. M. & Livermore, D. M. (1997). Bases of variation in resistance to β-lactams in Klebsiella oxytoca isolates hyperproducing K1 β-lactamase. Journal of Antimicrobial Chemotherapy 40, 533-41.
10. Jacoby, G. A. & Carreras, I. (1990). Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 34, 858-62.
11. Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J. & Bush, K. (1997). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrobial Agents and Chemotherapy 41, 563-9.
12. MacKenzie, F. M., Forbes, K. J., Dorai-John, T., Amyes, S. G. & Gould, I. M. (1997). Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet 350, 783.
13. Livermore, D. M. (1995). β-lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews, 8, 557-84.
14. Bush, K. (1996). Is it important to identify extended-spectrum β-lactamase-producing isolates? European Journal of Clinical Microbiology and Infectious Diseases 15, 361-4.